Peru study finds Sinopharm COVID vaccine 50.4% effective against infections - Reuters

10:14pm PDT - August 12th, 2021    health - Reuters

A two-dose COVID-19 vaccine from China's Sinopharm was 50.4% effective in preventing infections in health workers in Peru when it was seeing a surge in cases fuelled by virus variants, and booster shots can be considered, a study found.